How China started dominating the U.S. in the research sector

China is rapidly overtaking the United States as the global leader in research and development, a shift driven by massive financial investments in Chinese universities while American institutions face unprecedented funding disruptions. The impact of this transition is evident in the field of gene therapy for hereditary deafness, where Harvard Medical School professor David Corey saw his long-standing federal grants frozen due to political disputes, causing critical delays and loss of staff. In contrast, Dr. Eli Hsu at Fudan University in Shanghai—who was originally trained at Harvard—now operates a larger, better-funded lab that has already successfully restored hearing in a clinical trial. As China now claims seven of the top ten spots in global academic output rankings, American researchers warn that the U.S. is losing its competitive edge and economic opportunities, potentially forcing future patients to seek medical breakthroughs abroad.